Literature DB >> 16049307

Molecular cytogenetic analyses of immunoglobulin loci in nodular lymphocyte predominant Hodgkin's lymphoma reveal a recurrent IGH-BCL6 juxtaposition.

Christoph Renné1, José Ignacio Martín-Subero, Martin-Leo Hansmann, Reiner Siebert.   

Abstract

Chromosomal translocations juxtaposing different oncogenes to the immunoglobulin (IG) loci are the hallmark of various B-cell lymphomas. Because the tumor cells in nodular lymphocyte predominant Hodgkin's lymphoma (NLPHL) are also derived from B cells, we examined whether NLPHL harbors chromosomal translocations that affect IG loci. Fluorescence in situ hybridization was applied to 24 NLPHL cases using probes flanking the IGH, IGK, and IGL loci as well as the BCL6 gene. Fourteen of these cases were additionally analyzed by combined immunofluorescence and fluorescence in situ hybridization. Chromosomal breakpoints in the IGH locus were detected in five NLPHL. All these cases also contained a BCL6 breakpoint. Triple-color interphase cytogenetics demonstrated the presence of an IGH-BCL6 juxtaposition, indicating a t(3;14)(q27;q32) in all five cases. There was no evidence for breakpoints affecting the IGK or IGL loci. Our results show that translocations juxtaposing the BCL6 oncogene next to the IGH locus are recurrent in NLPHL.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16049307      PMCID: PMC1867541          DOI: 10.1016/S1525-1578(10)60564-8

Source DB:  PubMed          Journal:  J Mol Diagn        ISSN: 1525-1578            Impact factor:   5.568


  26 in total

1.  Heterogeneity of BCL6 rearrangements in nodular lymphocyte predominant Hodgkin's lymphoma.

Authors:  Iwona Wlodarska; Michel Stul; Chris De Wolf-Peeters; Anne Hagemeijer
Journal:  Haematologica       Date:  2004-08       Impact factor: 9.941

2.  Cytogenetic findings in nodular paragranuloma (Hodgkin's disease with lymphocytic predominance; nodular) and in progressively transformed germinal centers.

Authors:  M L Hansmann; E Gödde-Salz; P K Hui; H K Müller-Hermelink; K Lennert
Journal:  Cancer Genet Cytogenet       Date:  1986-04-15

3.  Nodular lymphocyte predominance Hodgkin's disease. A distinct clinicopathological entity.

Authors:  D Y Mason; P M Banks; J Chan; M L Cleary; G Delsol; C de Wolf Peeters; B Falini; K Gatter; T M Grogan; N L Harris
Journal:  Am J Surg Pathol       Date:  1994-05       Impact factor: 6.394

4.  Interphase cytogenetic analysis of lymphoma-associated chromosomal breakpoints in primary diffuse large B-cell lymphomas of the central nervous system.

Authors:  Manuel Montesinos-Rongen; Reina Zühlke-Jenisch; Stefan Gesk; José Ignacio Martín-Subero; Carlo Schaller; Dirk Van Roost; Otmar D Wiestler; Martina Deckert; Reiner Siebert
Journal:  J Neuropathol Exp Neurol       Date:  2002-10       Impact factor: 3.685

5.  Nodular paragranuloma can transform into high-grade malignant lymphoma of B type.

Authors:  M L Hansmann; H Stein; C Fellbaum; P K Hui; M R Parwaresch; K Lennert
Journal:  Hum Pathol       Date:  1989-12       Impact factor: 3.466

6.  Hodgkin's disease, lymphocyte predominance type, nodular--further evidence for a B cell derivation. L & H variants of Reed-Sternberg cells express L26, a pan B cell marker.

Authors:  G S Pinkus; J W Said
Journal:  Am J Pathol       Date:  1988-11       Impact factor: 4.307

7.  BCL6 gene translocation in follicular lymphoma: a harbinger of eventual transformation to diffuse aggressive lymphoma.

Authors:  Takashi Akasaka; Izidore S Lossos; Ronald Levy
Journal:  Blood       Date:  2003-05-08       Impact factor: 22.113

8.  Cytogenetic 2; 18 and 18; 22 translocation in chronic lymphocytic leukemia with juxtaposition of bcl-2 and immunoglobulin light chain genes.

Authors:  S Tashiro; M Takechi; H Asou; K Takauchi; T Kyo; H Dohy; M Kikuchi; N Kamada; Y Tsujimoto
Journal:  Oncogene       Date:  1992-03       Impact factor: 9.867

9.  Hodgkin's disease, lymphocytic predominance nodular. Increased risk for subsequent non-Hodgkin's lymphomas.

Authors:  M Miettinen; K O Franssila; E Saxén
Journal:  Cancer       Date:  1983-06-15       Impact factor: 6.860

10.  Frequent occurrence of BCL6 rearrangements in nodular lymphocyte predominance Hodgkin lymphoma but not in classical Hodgkin lymphoma.

Authors:  Iwona Wlodarska; Peet Nooyen; Brigitte Maes; José I Martin-Subero; Reiner Siebert; Patrick Pauwels; Chris De Wolf-Peeters; Anne Hagemeijer
Journal:  Blood       Date:  2002-09-12       Impact factor: 22.113

View more
  10 in total

Review 1.  Genomic alterations in Hodgkin's lymphoma.

Authors:  Marc A Weniger; Thomas F E Barth; Peter Möller
Journal:  Int J Hematol       Date:  2006-06       Impact factor: 2.490

2.  Coexisting and clonally identical classic hodgkin lymphoma and nodular lymphocyte predominant hodgkin lymphoma.

Authors:  Joo Y Song; Franziska C Eberle; Liqiang Xi; Mark Raffeld; Osama Rahma; Wyndham H Wilson; Kieron Dunleavy; Stefania Pittaluga; Elaine S Jaffe
Journal:  Am J Surg Pathol       Date:  2011-05       Impact factor: 6.394

Review 3.  [Nodular lymphocyte-predominant Hodgkin's lymphoma and differential diagnoses].

Authors:  S Hartmann; S Cogliatti; M-L Hansmann
Journal:  Pathologe       Date:  2013-05       Impact factor: 1.011

4.  [Nodular lymphocyte-dominant Hodgkin's lymphoma : LP cells show recurrent mutations in DUSP2, SGK1 and JUNB].

Authors:  S Hartmann
Journal:  Pathologe       Date:  2017-11       Impact factor: 1.011

Review 5.  Is Hodgkin lymphoma just another B-cell lymphoma?

Authors:  Harald Stein; Roshanak Bob
Journal:  Curr Hematol Malig Rep       Date:  2009-07       Impact factor: 3.952

Review 6.  An Update on the Pathology and Molecular Features of Hodgkin Lymphoma.

Authors:  Akira Satou; Taishi Takahara; Shigeo Nakamura
Journal:  Cancers (Basel)       Date:  2022-05-26       Impact factor: 6.575

7.  The RON receptor tyrosine kinase is a potential therapeutic target in Burkitt lymphoma.

Authors:  Xiangmin Tong; Xuewu Zhang; Jian Fan; Yin Tong; Shuangshuang Li; Jie Jin; Hangping Yao
Journal:  Cancer Biol Ther       Date:  2013-01-29       Impact factor: 4.742

8.  Recent Advances in the Pathobiology of Hodgkin's Lymphoma: Potential Impact on Diagnostic, Predictive, and Therapeutic Strategies.

Authors:  Diponkar Banerjee
Journal:  Adv Hematol       Date:  2011-01-18

Review 9.  Genomic Landscape of Hodgkin Lymphoma.

Authors:  Magdalena M Brune; Darius Juskevicius; Jasmin Haslbauer; Stefan Dirnhofer; Alexandar Tzankov
Journal:  Cancers (Basel)       Date:  2021-02-08       Impact factor: 6.639

10.  Origin and pathogenesis of nodular lymphocyte-predominant Hodgkin lymphoma as revealed by global gene expression analysis.

Authors:  Verena Brune; Enrico Tiacci; Ines Pfeil; Claudia Döring; Susan Eckerle; Carel J M van Noesel; Wolfram Klapper; Brunangelo Falini; Anja von Heydebreck; Dirk Metzler; Andreas Bräuninger; Martin-Leo Hansmann; Ralf Küppers
Journal:  J Exp Med       Date:  2008-09-15       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.